naringenin






562 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 3955304 Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lung. Br J Pharmacol 1986 Feb 1
2 7407100 The quenching of an intramembrane fluorescent probe. A method to study the binding and permeation of phloretin through bilayers. Biochim Biophys Acta 1980 Jul 1
3 7503800 Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharmacol 1995 Oct 26 1
4 7835232 Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 1994 Sep-Oct 1
5 7895601 Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. Drug Metab Dispos 1994 Nov-Dec 1
6 8161344 Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochem Pharmacol 1994 Mar 29 1
7 8450317 Cytotoxic principles and their derivatives of Formosan Solanum plants. J Nat Prod 1993 Jan 1
8 8485024 Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 1993 Apr 3
9 8924586 Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol 1996 Jan-Feb 1
10 9287415 Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells. J Nat Prod 1997 Aug 1
11 9449200 Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids. J Steroid Biochem Mol Biol 1997 Sep-Oct 1
12 9492341 Flavonoids inhibit estrogen binding to rat alpha-fetoprotein. Proc Soc Exp Biol Med 1998 Mar 2
13 9616184 Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 1998 Jun 2
14 9751507 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998 Oct 2
15 9766878 Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998 Sep 4 1
16 10397250 Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res 1999 Jul 1 2
17 10405973 Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids 1999 Jun 2
18 10406482 Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids 1999 May 1
19 10545673 Cholesterol-lowering activity of naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase in rats. Ann Nutr Metab 1999 2
20 10781868 Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000 Apr 3 1
21 10969720 An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000 Jul 1
22 11213362 Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001 Jan 12 1
23 11306701 Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol Pharmacol 2001 May 2
24 11352979 Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res 2001 May 11
25 11396955 Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun 2001 Jun 15 7
26 11454723 The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression. Drug Metab Dispos 2001 Aug 2
27 11540853 Identification of naturally occurring calmodulin inhibitors in plants and their effects on calcium- and calmodulin-promoted protein phosphorylation. Plant Cell Physiol 1985 1
28 12224631 Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids. Biosci Biotechnol Biochem 2002 Jul 1
29 12235187 Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters. J Lipid Res 2002 Sep 7
30 12485947 Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metab Dispos 2003 Jan 1
31 12564931 Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation. Biochemistry 2003 Feb 11 11
32 12673038 Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biol Pharm Bull 2003 Apr 1
33 12967034 Naringin and naringenin inhibit nitrite-induced methemoglobin formation. Pharmazie 2003 Aug 2
34 14514640 Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. Diabetes 2003 Oct 13
35 14698415 Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5. Mutat Res 2004 Jan 12 4
36 15030205 Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection. J Agric Food Chem 2004 Mar 24 4
37 15111768 Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat 2004 May 7
38 15205350 Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 2004 Jun 15 3
39 15276617 Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types. J Steroid Biochem Mol Biol 2004 Jul 2
40 15460448 Suppression of CYP1A1 expression by naringenin in murine Hepa-1c1c7 cells. Arch Pharm Res 2004 Aug 7
41 15531381 Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci 2004 Dec 3 2
42 15545229 Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. IUBMB Life 2004 Aug 1
43 15678369 Passive cutaneous anaphylaxis-inhibitory activity of flavanones from Citrus unshiu and Poncirus trifoliata. Planta Med 2005 Jan 4
44 15729616 Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin. Planta Med 2005 Feb 2
45 15750342 Polymorphism and expression of isoflavone synthase genes from soybean cultivars. Mol Cells 2005 Feb 28 4
46 15826879 Naringenin attenuates cisplatin nephrotoxicity in rats. Life Sci 2005 Mar 18 1
47 15911222 Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT? Eur J Pharm Sci 2005 Jun 1
48 15919788 Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 2005 Jun 18
49 15974445 Production of cytokine and NO by RAW 264.7 macrophages and PBMC in vitro incubation with flavonoids. Arch Pharm Res 2005 May 1
50 16007460 Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation. Naunyn Schmiedebergs Arch Pharmacol 2005 Jun 7